CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 42 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 4.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,726,154 | +4.7% | 730,472 | +0.2% | 0.77% | +24.5% |
| Q2 2023 | $4,512,987 | +60.8% | 729,077 | 0.0% | 0.62% | +71.5% |
| Q1 2023 | $2,806,946 | +23.4% | 729,077 | -0.7% | 0.36% | +3.7% |
| Q4 2022 | $2,275,171 | -22.6% | 733,926 | +0.3% | 0.35% | -43.7% |
| Q3 2022 | $2,941,000 | -20.3% | 731,521 | -3.5% | 0.62% | -34.3% |
| Q2 2022 | $3,691,000 | -38.5% | 757,848 | +13.3% | 0.94% | -51.6% |
| Q1 2022 | $6,002,000 | +123.0% | 669,100 | +179.9% | 1.95% | +35.3% |
| Q4 2021 | $2,692,000 | – | 239,041 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $299,329,000 | 65.12% |
| Vida Ventures Advisors, LLC | 3,931,818 | $65,661,000 | 18.81% |
| Samsara BioCapital, LLC | 1,537,533 | $25,677,000 | 4.03% |
| VR Adviser, LLC | 1,127,272 | $18,825,000 | 2.42% |
| Logos Global Management LP | 1,069,545 | $17,861,000 | 1.29% |
| Cormorant Asset Management, LP | 1,727,273 | $28,724,000 | 1.17% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $161,686,000 | 0.95% |
| Affinity Asset Advisors, LLC | 203,183 | $3,393,000 | 0.86% |
| RA Capital Management | 3,577,094 | $59,737,000 | 0.83% |
| Boxer Capital, LLC | 1,334,227 | $22,282,000 | 0.78% |